An investigation of the metabolic activity, isozyme contribution, species differences and potential drug–drug interactions of PI-103, and the identification of efflux transporters for PI-103-O-glucuronide in HeLa1A9 cells-Reference-Cited by-同舟云学术

An investigation of the metabolic activity, isozyme contribution, species differences and potential drug–drug interactions of PI-103, and the identification of efflux transporters for PI-103-O-glucuronide in HeLa1A9 cells

Published:2020 Issue:16 Volume:10 Page:9610-9622
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Gao Li¹²³⁴⁵,Qin Zifei¹²³⁴⁵^ORCID,Zhang Beibei¹²³⁴⁵,Yin Zhao¹²³⁴⁵,Zhang Xiaojian¹²³⁴⁵,Yang Jing¹²³⁴⁵

Affiliation:

1. Department of Pharmacy

2. The First Affiliated Hospital of Zhengzhou University

3. Zhengzhou 450052

4. China

5. Henan Key Laboratory of Precision Clinical Pharmacy

Abstract

Metabolic activity and disposition characteristics of PI-103.

Funder

National Natural Science Foundation of China

Foundation of Henan Educational Committee

Hospital Youth Foundation of First Affiliated Hospital of Zhengzhou University

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2020/RA/C9RA09906A

Reference40 articles.

1. The emerging mechanisms of isoform-specific PI3K signalling

2. Targeting the phosphoinositide 3-kinase pathway in cancer

3. Signalling through phosphoinositide 3-kinases: the lipids take centre stage

4. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism

5. A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of naturally occurring inhibitors in Xian-Ling-Gu-Bao capsule against the glucuronidation of estrogens;Frontiers in Pharmacology;2022-08-04

2. Arming Immune Cell Therapeutics with Polymeric Prodrugs;Advanced Healthcare Materials;2021-12-17

3. Potential Determinants for Metabolic Fates and Inhibitory Effects of Isobavachalcone Involving in Human Cytochrome P450, UDP-Glucuronosyltransferase Enzymes, and Efflux Transporters;Journal of Pharmaceutical Sciences;2021-05

4. Investigation on the metabolic characteristics of isobavachin in Psoralea corylifolia L. (Bu-gu-zhi) and its potential inhibition against human cytochrome P450s and UDP-glucuronosyltransferases;Journal of Pharmacy and Pharmacology;2020-08-04

5. Multiple circulating alkaloids and saponins from intravenous Kang-Ai injection inhibit human cytochrome P450 and UDP-glucuronosyltransferase isozymes: potential drug–drug interactions;Chinese Medicine;2020-07-06